ARGENX SE is 45.7x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($53.35 B vs $1.17 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COAG | ARGX |
|---|---|---|
| Market cap | $1.17 B | $53.35 B |
| US-listed rank | #2524 | #306 |
| SEC filings | 38 | 272 |
ARGENX SE is 45.7x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($53.35 B vs $1.17 B).
Full pages: Hemab Therapeutics Holdings, Inc. and ARGENX SE, or browse the full rankings.